Company intelligence / Profile preview

Advanced Imaging Projects

Lake Worth, Florida, United Statesorpha.net ↗

Ownership: Private
Development stage: Other

Overview

Advanced Imaging Projects LLC develops diagnostic and therapeutic radiopharmaceuticals targeting oncology and nervous system diseases. Its lead asset, 18F-Fluoromisonidazole, is in Phase 2 for hepatocellular carcinoma; other programs are at preclinical or contrast agent development stages. The company focuses on integrin-targeted agents for both diagnosis and therapy in cancer indications. No published clinical results were found as of early 2025.

Therapeutic areas: OncologyOther
Modalities: Diagnostic radiopharmaceuticalsTherapeutic radiopharmaceuticalsSmall molecule drugPeptide conjugate radionuclide
Industry: Biotech

Drug pipeline

2 assets

68Ga-NODAGA-THERANOST

Unknown

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Advanced Imaging Projects.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Imaging Projects.

Explore the full profile